The moment a pharmaceutical brand company files a new drug application with the FDA, a clock starts ticking. Somewhere across […]

How pharmaceutical companies engineer consumer psychology to extract billions from brand loyalty after patents expire — and what it means

Pharmaceutical brand teams spend millions monitoring what doctors, patients, and payers say about their drugs. Most of that investment goes

Every pharmaceutical company files patents to protect its investment. Every one of those patents is a public document. And yet,

The Fork in the Road That Determines Billions When a drug company files for FDA approval of a new medicine,

A complete operational guide to locating abandoned and lapsed pharmaceutical patents for generic market entry The Money Is in the

The Moment Everyone Prepares for and Nobody Fully Survives The day a blockbuster drug’s core patent expires is circled on

How chatbots became the most influential prescribing influencers in pharma, what happens when they get it wrong, and the monitoring

The math is brutal and straightforward. A branded drug generating $800 million annually can lose 80 to 90 percent of